AbbVie takes $2.1 billion charge on cancer drug ahead of US price negotiation

By Leroy Leo and Christy Santhosh (Reuters) -AbbVie, girding for government price negotiations on its big-selling cancer drug Imbruvica, on Friday disclosed a $2.1 billion charge related to an expected drop in revenue once the new price for U.S. Medicare patients goes into effect. The Illinois-based drugmaker’s leukemia pill in August was selected as one…

Read More

FedEx says U.S. Express service disrupted, blames FAA IT outage overnight

LOS ANGELES (Reuters) -FedEx Corp on Wednesday said its U.S. Express deliveries could be delayed due to an overnight Federal Aviation Administration (FAA) information technology system outage that the regulatory agency said has been resolved. FedEx’s signature Express service uses planes to provide overnight deliveries. The company said shipments delayed due to the outage are…

Read More

Alphabet shares sink as Microsoft extends cloud lead with focus on OpenAI

By Aditya Soni and Krystal Hu (Reuters) -Alphabet shares slumped on Wednesday after its cloud unit’s growth fell to near a three-year low, paling in comparison to Microsoft’s relative success as the tech giants race to make money from generative artificial intelligence. Shares of Alphabet fell 9.6% on Wednesday, compared with a healthy 2.8% gain…

Read More